background beta-lactam resistance in gram-negative bacteria, especially escherichia coli, is a main clinical problem. it is often caused by the co-production of β-lactamases, particularly extended-spectrum β-lactamases (esbls) and ampc enzymes. it may lead to a problem for diagnosis via recommended phenotypic tests by the clinical and laboratory standards institute (clsi). conversely, β-lactama...

Over a 4-month period from November 2002 to February 2003, 27 ceftazidime-resistant or cefotaxime-resistant nonrepetitive Enterobacter cloacae isolates were collected from 27 patients hospitalized at HuaShan Hospital, Shanghai, People's Republic of China. The Etest did not detect extended-spectrum beta-lactamases (ESBLs) in those 27 isolates; however, screening by the NCCLS ESBL disk test and c...

With the occurrence of extended-spectrum beta-lactamases (ESBLs) in Pseudomonas aeruginosa being increasingly reported worldwide, there is a need for a reliable test to detect ESBLs in clinical isolates of P. aeruginosa. In our study, a total of 75 clinical isolates of P. aeruginosa were studied. Nitrocefin tests were performed to detect the beta-lactamase enzyme; isoelectric focusing electroph...

Of 72 blood isolates of Enterobacter spp. collected over an 8-year period, 50% (36 of 72) were derepressed or partially derepressed AmpC mutants. The extended-spectrum -lactamase (ESBL) production rate was 43% (31 of 72 isolates), and 67.3% (31 of 46) of extended-spectrum cephalosporin-resistant strains produced ESBLs. Thus, a confirmatory test for ESBL production is necessary for extended-spec...

Objective. Since a urinary tract infection (UTI) is easy to relapse and difficult treat, the antibiotic resistance rate has increased year by in recent years. This study was analyze characteristics of common pathogenic bacteria changes system infection, so as guide standard use antibiotics clinical control nosocomial effectively. Methods. A total 5,669 strains hospital from January 2009 Decembe...

background: extended spectrum β-lactamases (esbls) and ampc β-lactamases enzyme are major sources of resistance to β-lactam antibiotics especially in enterobacteriaceae such as escherichia coli and klebsiella pneumoniae. increasing frequency of the co-existence of esbls with ampc-β-lactamases in bacteria is a serious threat for treating bacterial infections. conclusions: outbreak of isolates co...

Increasing frequency of infections caused by antibiotic resistant Escherichia coli strains producing extended-spectrum β-lactamase (ESBL) needs to be addressed by continuous surveillance and accurate detection of specific ESBLs genes for more effective treatment. A total of 71 β-lactam drug resistant isolates (26 phenotypically ESBL-producing and 45 non-ESBLproducing) were observed to carry app...

This study was aimed to determine the prevalence of ESBLs in E. coli and their relation plasmid profiling patterns a sample patients Iraqi hospitals. The total number isolates 91 (49%) were collected out 185 clinical samples. antibiotic sensitivity test for showed high resistance percentage Nitrofurantion 95.7%, amoxicillin Ceftriaxone each which 91.3% Ceftazidime 90.2%, while highest observed ...